Strategies for using cytoprotective agents to improve outcomes associated with cancer chemotherapy - Results of a randomized control trial in patients with advanced ovarian cancer

By Goodin S.   DiPaola R.S.  

Disease Management and Clinical Outcomes, Vol. 1, Iss. 5, 1998-09 ,pp. : 155-160

Elsevier

Access to resources Recommend Favorite

Stated Preferences of Patients with Cancer for Health-related Quality-of-life (HRQOL) Domains During Treatment

By Osoba David   Hsu Ming-Ann   Copley-Merriman Catherine   Coombs John   Johnson F.   Hauber Brett   Manjunath Ranjani   Pyles Amanda  

Quality of Life Research, Vol. 15, Iss. 2, 2006-03 ,pp. : 273-283

Springer Publishing Company

Access to resources Recommend Favorite

Health state preferences are equivalent in the United States and Trinidad and Tobago

By Hector Richard   Anderson John   Paul Rosemarie   Weiss Robert   Hays Ron   Kaplan Robert  

Quality of Life Research, Vol. 19, Iss. 5, 2010-06 ,pp. : 729-738

Springer Publishing Company

Access to resources Recommend Favorite

Recent advances in drug delivery strategies for treatment of ovarian cancer

By Zahedi Payam   Yoganathan Roshan   Piquette-Miller Micheline   Allen Christine  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 5, 2012-05 ,pp. : 567-583

Informa Healthcare

Access to resources Recommend Favorite

Health related quality of life in different states of breast cancer

By Lidgren Mathias   Wilking Nils   Jönsson Bengt   Rehnberg Clas  

Quality of Life Research, Vol. 16, Iss. 6, 2007-08 ,pp. : 1073-1081

Springer Publishing Company

Access to resources Recommend Favorite